Literature DB >> 33664468

Falling insulin requirement in late pregnancy: association with obstetric and neonatal outcomes.

Barbara Wilkinson1, Marie McDonnell2, Nadine Palermo2, Sarah Lassey3, Sarah Little3.   

Abstract

OBJECTIVE: To investigate whether diminishing insulin requirement in the third trimester is associated with placental dysfunction. STUDY
DESIGN: Two-year retrospective cohort study at one tertiary care center of women with pregestational or gestational diabetes, their insulin requirements, and complications associated with placental dysfunction.
RESULTS: Of 157 women, 21 (13%) experienced declining insulin requirement, with average decline of 28% at 34 weeks. They were more likely to have pregestational diabetes (71.4% vs. 42.6%; p < 0.01) and delivered earlier (median 36w4d vs. 37w4d; p < 0.01). There was no difference in placental dysfunction related complications (33% vs. 24%; p = 0.37). There was an increased rate of polyhydramnios (42.9% vs. 8.8%; p < 0.01). NICU admission (62% vs. 33%; p < 0.01) and neonatal respiratory distress (52% vs. 24%; p < 0.01) was higher in cases of declining insulin requirement independent of gestational age.
CONCLUSIONS: A decline in insulin requirement should raise concern for increased risk of NICU admission and neonatal respiratory distress.

Entities:  

Year:  2021        PMID: 33664468     DOI: 10.1038/s41372-021-00979-x

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  3 in total

1.  Maternal, fetal and amniotic fluid levels of glucose, insulin and growth hormone.

Authors:  W N Spellacy; W C Buhi; B Bradley; K K Holsinger
Journal:  Obstet Gynecol       Date:  1973-03       Impact factor: 7.661

2.  Insulin requirements during pregnancy in women with type I diabetes.

Authors:  J M Steel; F D Johnstone; R Hume; J H Mao
Journal:  Obstet Gynecol       Date:  1994-02       Impact factor: 7.661

3.  Amniotic fluid glucose values in normal and abnormal pregnancies.

Authors:  P A Weiss; H Hofmann; R Winter; P Pürstner; W Lichtenegger
Journal:  Obstet Gynecol       Date:  1985-03       Impact factor: 7.661

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.